Gapping down
In reaction to disappointing earnings/guidance: KN -21%, ZNGA -12.4%, MGI -5.2%, CAG -3.6%, SCOK -3.6%, SFLY -3.2%, IMI -3.2%, CPB -3.2%, (guides Q2, FY15 EPS below consensus, rev in-line), HOLI -3.1%, SYMX -3%, GRPN -2%, AIG -1.8%, KRFT -1.8%, (announces George Zoghbi as new COO ), SSNC -1.6%, TSU -1.6%, DLR -0.9%, TNGO -0.5%
Select airline related names showing weakness: ALK -1.2%, LUV -1.1%, GOL -1%, DAL -0.7%, AAL -0.5%
Other news: MX -49.4% (co completed the restatement of its financial filings), PRAN -20.1% (FDA has issued a partial clinical hold letter for PBT2), BLDP -5.5% (pulling back following recent strength), SDRL -2.7% (provides update on Petrobras (PBR) contracts), IDRA -2.4% (attributed to pricing of secondary), ARMH -1.9% (still checking)
Analyst comments: GFI -2.4% (downgraded to Underweight from Neutral at HSBC Securities), ZTS -1.7% (downgraded to Neutral from Overweight at JP Morgan), BWA -1.4% (downgraded to Neutral from Buy at Goldman), TOT -1.2% (downgraded to Neutral from Buy at UBS), TSO -1.1% (downgraded to Neutral from Buy at Goldman -- Removed from Conviction Buy List), GPS -1% (downgraded to Underperform from Neutral at Credit Suisse), AXP -0.8% (downgraded to Underperform from Buy at BofA/Merrill)
In reaction to disappointing earnings/guidance: KN -21%, ZNGA -12.4%, MGI -5.2%, CAG -3.6%, SCOK -3.6%, SFLY -3.2%, IMI -3.2%, CPB -3.2%, (guides Q2, FY15 EPS below consensus, rev in-line), HOLI -3.1%, SYMX -3%, GRPN -2%, AIG -1.8%, KRFT -1.8%, (announces George Zoghbi as new COO ), SSNC -1.6%, TSU -1.6%, DLR -0.9%, TNGO -0.5%
Select airline related names showing weakness: ALK -1.2%, LUV -1.1%, GOL -1%, DAL -0.7%, AAL -0.5%
Other news: MX -49.4% (co completed the restatement of its financial filings), PRAN -20.1% (FDA has issued a partial clinical hold letter for PBT2), BLDP -5.5% (pulling back following recent strength), SDRL -2.7% (provides update on Petrobras (PBR) contracts), IDRA -2.4% (attributed to pricing of secondary), ARMH -1.9% (still checking)
Analyst comments: GFI -2.4% (downgraded to Underweight from Neutral at HSBC Securities), ZTS -1.7% (downgraded to Neutral from Overweight at JP Morgan), BWA -1.4% (downgraded to Neutral from Buy at Goldman), TOT -1.2% (downgraded to Neutral from Buy at UBS), TSO -1.1% (downgraded to Neutral from Buy at Goldman -- Removed from Conviction Buy List), GPS -1% (downgraded to Underperform from Neutral at Credit Suisse), AXP -0.8% (downgraded to Underperform from Buy at BofA/Merrill)